Koers Genex Pharmaceutical, Inc. Other OTC
Aandelen
GENX
US37227T1051
Geavanceerde medische apparatuur & technologie
Omzet 2006 | 2,44 mln. 2,28 mln. | Omzet 2007 | 3,24 mln. 3,03 mln. | Marktkapitalisatie | 5,18 mln. 4,84 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2006 | - 0 | Nettowinst (verlies) 2007 | - 0 | EV/omzet 2006 | 0,95 x |
Nettoliquiditeiten 2006 | 0,19 0,18 | Nettoschuld 2007 | 0,14 0,14 | EV/omzet 2007 | 1,6 x |
K/w-verhouding 2006 |
3,75
x | K/w-verhouding 2007 |
15,1
x | Werknemers | - |
Dividendrendement 2006 * |
-
| Dividendrendement 2007 |
-
| Vrij verhandelbaar | 99,62% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Fuzhi Song
CEO | Chief Executive Officer | 70 | 17-06-04 |
Shuli Zhang
DFI | Director of Finance/CFO | 70 | 17-06-04 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Fuzhi Song
CEO | Chief Executive Officer | 70 | 17-06-04 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,07% | 219 mld. | |
+6,59% | 183 mld. | |
+11,26% | 133 mld. | |
+26,57% | 108 mld. | |
+0,65% | 63,06 mld. | |
+13,35% | 52,02 mld. | |
-0,62% | 48,2 mld. | |
-0,93% | 40,37 mld. | |
+11,54% | 39,35 mld. |